0139 GMT November 27, 2021
Iran will import 60 million doses of COVID-19 vaccines by the end of October, said the president of the Iranian Red Crescent Society (IRCS).
In an address to meeting with his deputies, Karim Hemmati added that regular sessions attended by Iran’s First Vice President Mohammad Mokhber and vaccine importers and producers are constantly being held to ensure a continuous COVID jab supply, IRNA reported.
He noted that in October, Iran will import 10 million doses of COVID-19 vaccines per week, expressing hope that following the complete inoculation of the country’s people, a major step would be taken toward immunizing the Iranian society against the disease.
Hemmati said the first vice president’s cooperation in and contribution to the process of granting import permits is among the reasons for the increased pace of the COVID-19 vaccine delivery to the country.
He added that in view of the large number of imported vaccine doses, all domestic health and treatment organizations and centers are required to take part in the public vaccination process, saying the country’s Armed Forces and IRCS have already expressed readiness to participate in the process, which will help significantly reduce the burden shouldered by the Health Ministry and accelerate public inoculation.
In remarks on Sunday, Iran’s Health Minister Bahram Einollahi said the ministry is pushing a door-to-door vaccination campaign to immunize more Iranians against the coronavirus.
He added health workers will be dispatched to various parts of the country to vaccinate those who have missed invitations to come to state-run inoculation facilities.
Einollahi noted that the campaign would ensure the quality and integrity of Iran’s vaccination drive against the coronavirus.
The comments come as Iran is racing against the time to complete a COVID inoculation program that got off to a very slow start in December 2020.
Einollahi said vaccinations could exceed a record of eight million doses per week.
Iran’s public vaccination process has gained greater momentum over the past few weeks in view of the rise in imports and domestic production of vaccines, setting new daily records.
The country has received several COVID-19 vaccine batches from Russia (Sputnik V), China (Sinopharm), Japan (AstraZeneca) and India (COVAXIN), and has also developed a number of COVID jabs domestically, including one dubbed COVIran Barekat (Barakat Foundation), a jab named Soberana 2, or PastoCoVac (Cuba’s Instituto Finlay de Vacunas and Iran’s Pasteur Institute) and a vaccine known as Fakhra (Defense Ministry).
The other two COVID jabs being developed in the country are Noura (the Islamic Revolution Guards Corps) and Razi Cov Pars (Razi Vaccine and Serum Research Institute).
According to figures by the Islamic Republic of Iran Customs Administration, Sinopharm accounts for the biggest share (37,529,596 doses) of the country’s jab purchases.
Iran’s Health Ministry announced in a statement on Monday that the country’s daily COVID-19 deaths and infections reached 344 and 17,397, respectively, in the past 24 hours.
The statement added the total COVID-19 death toll and infections since the beginning of the outbreak in the country in late February 2020 stand at 117,526 and 5,442,232, respectively.
The ministry said, 6,707 COVID-19 patients are in critical condition, and of the newly-detected cases, 2,593 individuals have been hospitalized.
It added 4,792,117 COVID-19 patients have so far either recovered from the disease or have been discharged from hospitals.
The statement added 31,113,929 coronavirus diagnostic tests have so far been carried out in the country and 44,423,948 doses of COVID-119 vaccines have been administered.
The Health Ministry said 57 cities in the country are coded red (very high-risk), while 238 are in the orange zone (high-risk).
The number of the country’s yellow (medium-risk) and blue (low-risk) cities are 136 and 17, respectively, according to the ministry.
Iran has been grappling with a fifth wave of the COVID-19 pandemic since a few weeks ago, mainly sparked by the spread of the Indian coronavirus variant, known as Delta, seeing a resurgence in deaths and infections. The number of casualties has, however, been declining since a few days ago, indicating that the country is past the peak of the fifth wave’s infections and deaths.